DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Glynase (Glyburide) - Current Clinical Trials

 
 



Glynase Related Clinical Trials

Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus. [Terminated]

A Study to Assess the Effects of Canagliflozin (JNJ-28431754) on the Pharmacokinetics, Pharmacodynamics, and Safety of Glyburide in Healthy Volunteers [Completed]

Glyburide Healthy Volunteer Study [Completed]

Glyburide (RP-1127) for Traumatic Brain Injury (TBI) [Active, not recruiting]

Glyburide and Metformin for the Treatment of Gestational Diabetes Mellitus. Systematic Review [Completed]

Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension [Recruiting]

Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes [Recruiting]

Bioavailability of BI 1356 and Glyburide in Healthy Male and Female Volunteers [Completed]

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions [Completed]

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Fasting Conditions [Completed]

A Relative Bioavailability Study of Glyburide/Metformin HCl 5 mg/500 mg Tablets Under Non-fasting Conditions [Completed]

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed [Completed]

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fasting [Completed]

Glibenclamide (Dose to be Titrated From Starting Dose of 5mg om) Plus Rosiglitazone 4mg om (Increased to 8mg om After 6 Months) and vs Glibenclamide (Dose to be Titrated With Starting Dose of 5mg om) Plus Placebo, Administered to Patients With Type 2 Diabetes Mellitus [Completed]

Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (GCC 1465) [Not yet recruiting]

Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK) [Withdrawn]

Effect of GlucoNorm vs Glyburide on Post-Prandial Hyperglycemia in Elderly Subjects With Type 2 Diabetes [Completed]

Glyburide and Metformin for Gestational Diabetes Mellitus (GDM) [Active, not recruiting]

Metformin Compared to Glyburide in Gestational Diabetes [Completed]

Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease [Completed]

R230C and C230C Variants of ABCA1 and Glyburide Response [Completed]

Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355) [Recruiting]

Glyburide Compared to Insulin in the Management of White's Classification A2 Gestational Diabetes [Withdrawn]

Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM [Completed]

Glyburide Advantage in Malignant Edema and Stroke Pilot [Completed]

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide [Completed]

Multicenter Randomized Trial of Non-inferiority Between Glyburide and Insulin for the Treatment of Gestational Diabetes [Recruiting]

Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM [Completed]

Safety Study of Pioglitazone Compared To Glyburide on Liver Function [Completed]

Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure [Terminated]

Treatment of Mild Gestational Diabetes With Glyburide Versus Placebo [Active, not recruiting]

Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes [Not yet recruiting]

Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. [Completed]

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes. [Completed]

Risk of Hypoglycemia in Type 2 Diabetes [Active, not recruiting]

Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide [Recruiting]

A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteS [Recruiting]

A Comparison Between Two Oral Hypoglycemics - Metformin and Glybenclamide for the Treatment of Gestational Diabetes Mellitus [Enrolling by invitation]

Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients [Completed]

Glyburide Opportunity for Spinal Cord Injury Protection [Recruiting]

Safety Study of RP-1127 (Glyburide for Injection) in Healthy Volunteers [Completed]

AVANDIA With Glyburide In African American And Hispanic Patients With Type 2 Diabetes Not Controlled by Glyburide Alone [Completed]

Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels [Not yet recruiting]

GALLANT 4 Tesaglitazar vs. Glibenclamide [Terminated]

Cardioprotective Effects of GLP-1 and Their Mechanisms [Not yet recruiting]

Oral Antidiabetic Agents in Pregnancy [Recruiting]

A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas [Completed]

Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion Injury [Recruiting]

Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes [Terminated]

Preferred Treatment of Type 1.5 Diabetes [Completed]

Gestational Diabetes: Insulin or Oral Hypoglycemic Agents? [Active, not recruiting]

Sulphonylurea Receptor Mutation and Responsiveness to Gliclazide - a Pilot Proof of Concept, Randomised Cross-over Study [Recruiting]

Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes Mellitus [Completed]

Preservation of Beta-cell Function in Type 2 Diabetes Mellitus [Completed]

A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes [Completed]

The Effect of Sitagliptin on Hypertension, Arterial Stiffness, Oxidative Stress and Inflammation [Recruiting]

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes [Completed]

A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus [Terminated]

Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes [Completed]

Efficacy of Repaglinide in Subjects With Type 2 Diabetes [Completed]

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes. [Completed]

To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies [Completed]

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus. [Completed]

A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion [Completed]

Type 2 Diabetes Patients Switched From Sulfonylurea With Metformin to Glyburide/Metformin Combination Tablet [Completed]

Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes [Completed]

Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DM [Recruiting]

Comparison of Glucovance to Insulin for Diabetes During Pregnancy [Recruiting]

PPAR-COMBO With Sulfonylurea [Completed]

GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes [Terminated]

Glimepiride Induced Insulin Secretion Will be Inhibited by Hypoglycemia [Completed]

Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus [Recruiting]

Pharmacogenetic Effect on the Pharmacodynamics of Glibenclamide [Recruiting]

Insulin Glargine in Type 2 Diabetic Patients [Completed]

Incretin and KATP Channels [Recruiting]

Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial [Active, not recruiting]

MK-3102 Phase III Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015 AM1) [Completed]

Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 Diabetes [Completed]

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment [Completed]

Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy [Active, not recruiting]

Ischemic Injury and Ischemic Preconditioning in Diabetes [Completed]

GALLANT 7 Tesaglitazar Add-on to Sulphonylurea [Terminated]

Malignancy Meta Analysis for BRL49653 [Completed]

Incretin-based Drugs and Acute Pancreatitis [Completed]

Incretin-based Drugs and Pancreatic Cancer [Completed]

Incretin-based Drugs and the Risk of Heart Failure [Completed]

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients [Completed]

Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers [Completed]

Rosiglitazone on Microalbuminuria in Type 2 Diabetics [Completed]

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus [Completed]

Fracture Risk With Thiazolidinediones [Completed]

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes [Withdrawn]

Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea [Not yet recruiting]

A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes [Completed]

Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263) [Completed]

Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes [Completed]

An Observational Study of Type II Diabetics Treated With Dual Therapy With or Without Sitagliptin (JanuviaŽ/XeleviaŽ, MK-0431-201) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017